Indoco Remedies Ltd.

NSE: INDOCO | BSE: 532612 | ISIN: INE873D01024 | Industry: Pharmaceuticals
| Momentum Trap
273.5500 0.45 (0.16%)
NSE Sep 05, 2025 15:31 PM
Volume: 9,873
 

273.55
0.16%
ICICI Securities Limited
Domestic formulations (~57% of FY18 revenues) have grown at 9% CAGR in FY13-18. The subdued growth can be attributed to high concentration of acute therapies that account for ~80% of overall formulations. With a market share of ~0.7% and overall rank of 31, the company is still a marginal player with some top brands in smaller categories like stomatologicals. However, with a positive outcome of restructuring exercise and improvement in MR productivity, we expect FY20E Indian formulations to deliver ~9% growth in FY18-20E to | 706 crore....
Indoco Remedies Ltd. has lost -27.94% in the last 1 Year
More from Indoco Remedies Ltd.
Recommended